| |
|
GROUP |
| |
|
2009 |
2008 |
| |
Notes |
R’000 |
R’000 |
| Revenue |
|
16 283 914 |
14 884 376 |
| Cost of goods sold |
|
(11 732 874) |
(11 003 343) |
| Gross profit |
|
4 551 040 |
3 881 033 |
| Other income |
|
105 538 |
111 813 |
| Biological assets fair value adjustments |
3 |
179 910 |
69 607 |
| Distribution costs |
|
(1 264 039) |
(1 204 075) |
| Administrative expenses |
|
(311 584) |
(290 090) |
| Other operating expenses |
|
(2 100 859) |
(1 703 230) |
| Items of a capital nature |
4 |
(68 022) |
(19 369) |
| Operating profit |
3 |
1 091 984 |
845 689 |
| Investment income |
5 |
28 715 |
31 472 |
| Finance costs |
6 |
(224 554) |
(250 786) |
| Profit from associated companies |
|
439 |
718 |
| Profit before income tax |
|
896 584 |
627 093 |
| Income tax expense |
7 |
(334 915) |
(174 408) |
| Profit for the year |
|
561 669 |
452 685 |
| Attributable to: |
|
|
|
| Equity holders of the Group |
|
560 519 |
452 146 |
| Minority interest |
|
1 150 |
539 |
| |
|
561 669 |
452 685 |
| Earnings per ordinary share (cents) |
8 |
320.8 |
282.3 |
| Diluted earnings per ordinary share (cents) |
8 |
315.7 |
275.5 |
| Dividend per ordinary share (cents) |
9 |
125.0 |
96.0 |
